omniture
Oscotec Inc.

Latest News

FDA Grants Orphan Drug Designation to Cevidoplenib for ITP

PANGYO, South Korea, March 21, 2024 /PRNewswire/ -- Oscotec Inc. has secured orphan drug designatio...

2024-03-21 20:00 1602

Oscotec/ADEL Initiates First-in-Human Dosing in Ph1 of Anti-MTBR Tau Antibody ADEL-Y01 In Alzheimer's Disease

PANGYO, South Korea, Feb. 23, 2024 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced the dosing ...

2024-02-23 21:00 1963

Oscotec/ADEL Announce FDA Clearance of IND Application of ADEL-Y01 for the Treatment of Alzheimer's Disease

PANGYO, South Korea, Sept. 14, 2023 /PRNewswire/ -- Oscotec Inc. and ADEL Inc. announced that the U...

2023-09-14 20:00 1505

Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib

* With the efficacy comparable to rival drugs, Oscotec plans to advance to the next step, leaving...

2023-02-24 22:00 3552